Regenxbio RGNX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $34.47M-40.1% | $57.53M+66.6% | $34.52M-64.4% | $96.95M-71.9% | ||
| $195.6M+10.4% | $177.16M-26.4% | $240.74M-10.1% | $267.69M+139% | ||
| $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | ||
| $26.38M+28.8% | $20.47M-17.4% | $24.79M-11.7% | $28.08M-13.4% | ||
| $11.93M+31.5% | $9.07M-37.6% | $14.52M+4.5% | $13.9M-25.9% | ||
| $281.28M+1.2% | $278M-17.0% | $334.97M-19.5% | $415.98M-19.8% | ||
| $104.86M-10.8% | $117.59M-11.0% | $132.1M-6.8% | $141.69M+7.7% | ||
| $47.16M-12.2% | $53.72M-11.2% | $60.49M-7.1% | $65.12M+6.9% | ||
| $4.61M+15.3% | $4M-16.8% | $4.81M-24.9% | $6.4M-0.5% | ||
| $453.03M-2.8% | $465.99M-18.8% | $573.97M-31.1% | $833.27M-25.2% | ||
| $21.36M-6.3% | $22.8M+0.1% | $22.79M-16.3% | $27.21M+139% | ||
| $10.45M+8,989% | $115K-22.3% | $148K-91.9% | $1.83M-45.1% | ||
| $8.29M+4.9% | $7.9M+11.8% | $7.07M+17.9% | $6M+242% | ||
| $18.94M— | —— | —— | —— | ||
| $118.1M+14.4% | $103.19M-20.8% | $130.27M-0.1% | $130.43M0.0% | ||
| $65.22M-12.0% | $74.13M-9.8% | $82.22M-7.4% | $88.8M+4.6% | ||
| $638K-82.4% | $3.64M-41.8% | $6.25M-29.2% | $8.83M+1,086% | ||
| $350.3M+69.8% | $206.34M-21.3% | $262.23M-17.3% | $317.07M-9.3% | ||
| $5K0.0% | $5K+25.0% | $4K0.0% | $4K0.0% | ||
| $1.23B+3.1% | $1.19B+16.8% | $1.02B+4.9% | $973.15M+4.9% | ||
| -$1.13B-20.8% | -$932.15M-32.2% | -$705.05M-59.7% | -$441.55M-174% | ||
| -$687K+7.3% | -$741K+83.3% | -$4.43M+71.2% | -$15.4M-499% | ||
| $102.73M-60.4% | $259.65M-16.7% | $311.74M-39.6% | $516.2M-32.5% | ||
| $453.03M-2.8% | $465.99M-18.8% | $573.97M-31.1% | $833.27M-25.2% | ||
| $195.6M+10.4% | $177.16M-26.4% | $240.74M-10.1% | $267.69M+139% | ||
| $12.91M-6.3% | $13.77M-32.5% | $20.4M+118% | $9.35M-8.3% | ||
| $4.61M+15.3% | $4M-16.8% | $4.81M-24.9% | $6.4M-0.5% | ||
| $2.31M+388% | $474K-32.4% | $701K-53.4% | $1.5M-33.5% | ||
| $47.16M-12.2% | $53.72M-11.2% | $60.49M-7.1% | $65.12M+6.9% | ||
| $47.16M-12.2% | $53.72M-11.2% | $60.49M-7.1% | $65.12M+6.9% | ||
| $4.61M+15.3% | $4M-16.8% | $4.81M-24.9% | $6.4M-0.5% | ||
| $47.16M-12.2% | $53.72M-11.2% | $60.49M-7.1% | $65.12M+6.9% | ||
| $4.61M+15.3% | $4M-16.8% | $4.81M-24.9% | $6.4M-0.5% | ||
| $18.94M— | —— | —— | —— | ||
| $38.39M+0.8% | $38.07M-23.4% | $49.7M+6.2% | $46.79M-38.5% | ||
| $39.61M+15.4% | $34.31M— | —— | —— | ||
| $18.94M— | —— | —— | —— | ||
| $18.94M— | —— | —— | —— | ||
| $73.5M-10.4% | $82.03M-8.1% | $89.29M-5.8% | $94.8M+9.4% | ||
| $1.23B+3.1% | $1.19B+16.8% | $1.02B+4.9% | $973.15M+4.9% | ||
| $5K0.0% | $5K+25.0% | $4K0.0% | $4K0.0% | ||
| $11.93M+31.5% | $9.07M-37.6% | $14.52M+4.5% | $13.9M-25.9% | ||
| $147.41M+481% | $25.38M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Regenxbio's total assets?
- Regenxbio (RGNX) holds $341.9M in total assets, down 30.4% year over year.
- How much debt does Regenxbio have?
- Regenxbio carries $71.1M in total debt against $21.1M of shareholders' equity, a debt-to-equity ratio of 3.37.
- How much cash does Regenxbio have?
- Regenxbio holds $15.2M in cash and equivalents.
- Can Regenxbio cover its short-term obligations?
- Its current ratio is 2.62 — current assets exceed current liabilities.
- Where does Regenxbio's balance sheet data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
